Skip to main content

Table 4 Lesion and procedural characteristics

From: Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation

 

DM (n = 149)

Non-DM (n = 188)

p value

Follow-up duration, days

115 ± 29

121 ± 25

0.031

Evidence of ischemia, n (%)

  

0.006

Exercise tests

6 (4)

12 (6)

 

Scintigraphy

25 (17)

17 (9)

 

FFR/iFR

12 (8)

4 (2)

 

None

106 (71)

155 (82)

 

Acute coronary syndrome, n (%)

45 (30)

78 (42)

0.040

Target vessel, n (%)

  

0.18

Left anterior descend artery

44 (30)

66 (35)

 

Left circumflex artery

64 (43)

85 (45)

 

Right coronary artery

35 (23)

27 (15)

 

Left main trunk

6 (4)

10 (5)

 

Heavy calcification, n (%)

17 (11)

19 (10)

0.42

Bifurcation, n (%)

53 (36)

73 (39)

0.31

Chronic total occlusion, n (%)

4 (3)

13 (7)

0.063

ACC/AHA classification, n (%)

 Type A/ B1/ B2/ C

15 (10)/ 26 (17)

/ 24 (16)/ 84 (56)

20 (11)/ 34 (18)

/ 41 (22)/ 93 (50)

0.53

Pre-dilatation balloon

 Maximum diameter, mm

2.63 ± 0.53

2.66 ± 0.52

0.73

 Maximum pressure, atm

13 ± 4

13 ± 3

0.78

 Maximum stent diameter, mm

3.04 ± 0.45

3.12 ± 0.40

0.069

 Minimum stent diameter, mm

2.92 ± 0.43

3.02 ± 0.43

0.030

 Total stent length, mm

31 ± 16

31 ± 20

0.86

 Stent implantation pressure, atm

12 ± 3

12 ± 3

0.85

Post-dilatation balloon

 Maximum diameter, mm

3.20 ± 0.56

3.28 ± 0.65

0.28

 Maximum pressure, atm

17 ± 4

16 ± 4

0.31

 Number of stents

1.2 ± 0.4

1.2 ± 0.4

0.91

Usage of intravascular imaging device, n (%)

  

0.19

Intravascular ultrasound

118 (79)

162 (86)

 

Optical coherence tomography

28 (19)

22 (12)

 

None

3 (1)

4 (1)

 

Type of DES

  

0.21

Cypher

1 (1)

2 (1)

 

Taxus

0 (0)

1 (1)

 

Endeavor

28 (19)

50 (27)

 

Xience

30 (20)

32 (17)

 

Promus

0 (0)

4 (2)

 

Resolute

35 (23)

38 (20)

 

Synergy

26 (17)

24 (13)

 

Ultimaster

21 (14)

23 (12)

 

Orsiro

0 (0)

3 (2)

 

BioFreedom

8 (5)

11 (6)

 

QCA data

   

Pre-PCI

   

Minimum lumen diameter, mm

0.95 ± 0.57

0.86 ± 0.57

0.14

Reference diameter, mm

2.65 ± 0.69

2.78 ± 0.80

0.11

Diameter stenosis, %

64 ± 20

70 ± 19

0.020

Lesion length, mm

15 ± 9

17 ± 12

0.13

Post-PCI

   

Minimum lumen diameter, mm

2.39 ± 0.52

2.52 ± 0.51

0.028

Reference diameter, mm

2.85 ± 0.55

3.03 ± 0.59

0.005

Diameter stenosis, %

16 ± 8

17 ± 8

0.50

  1. Data are presented as mean ± SD or number (%)
  2. DES  drug-eluting stent, DM diabetes mellitus, FFR  fractional flow reserve, iFR  instantaneous wave-free ratio, PCI  percutaneous coronary intervention, QCA  quantitative coronary angiography